Stay updated on ZFN Therapeutic SB-318 in MPS I Clinical Trial
Sign up to get notified when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.

Latest updates to the ZFN Therapeutic SB-318 in MPS I Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows Revision: v3.3.2 replacing v3.3.1, a minor site revision tag that does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedPublication sourcing wording updated to 'automatically filled in from PubMed' and the Revision: v3.3.1 tag added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedFunding/operating-status notice has been removed; study details and links remain unchanged.SummaryDifference0.4%

- Check41 days agoChange DetectedThe study details page shows only formatting/layout updates; core study information remains unchanged (eligibility criteria, outcomes, enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange Detected- Added a government-funding lapse notice and operating status details; updated to version v3.2.0. - Removed reference to v3.1.0.SummaryDifference4%

- Check77 days agoChange Detected- Capitalization correction: Hurler-Scheie syndrome (from Hurler-scheie syndrome). - Version tag update: Revision: v3.1.0 (from v3.0.2).SummaryDifference0.2%

Stay in the know with updates to ZFN Therapeutic SB-318 in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.